Gapping up
In reaction to strong earnings/guidance:
- SGH +14.5%, EMKR +13.8% (raises Q4 revenue guidance), HIMX +5.9% (Q3 guidance)
M&A news:
- PDS +0.9% (to acquire all shares of Trinidad Drilling in deal worth $1.028 bln)
Other news:
- GPRO +6.9% (announces that HERO7 Black has achieved the highest week-one retail unit sell-thru of any new camera in the company's history)
- PXLW +6.5% (after announcing the new Nokia 7.1 smartphone incorporates Pixelworks' latest Iris PX8418 mobile processing chip)
- NBEV +6% (preparing CBD-infused beverage launch with pre-order discussions, according to Bloomberg)
- AKCA +4.9% (Akcea Therapeutics and Ionis Pharmaceuticals (IONS) announce that TEGSEDI has been approved in Canada)
- TLRY +4.7% (prices an upsized offering of $450 mln aggregate principal amount of Convertible Senior Notes due 2023)
- SNAP +4.5% (reports that CEO Evan Spiegel emailed employees outlining priorities, discussed flaws of 'rushed redesign', and established goal of profitability in 2019)
- MNOV +4.4% (confirms being granted FDA orphan-drug designation to MN-166 as adjunctive therapy to temozolomide for the treatment of glioblastoma)
- VSTM +3.8% (indicated higher following the publication of the Phase 3 DUO study results evaluating COPIKTRA in peer-reviewed journal Blood)
- PRTK +3.4% (announces acceptance of European Marketing Authorization application for oral and intravenous omadacycline)
- FOLD +3.1% (announces positive 18-month data in Pompe disease phase 1/2 study)
Analyst comments:
- BJRI +2% (upgraded to Overweight from Neutral at Piper Jaffray)
- LLY +1.3% (upgraded to Outperform from Market Perform at BMO Capital Markets)
- QNST +0.6% (initiated with Outperform at William Blair)
![]()